CLEC4E and cancer: A plethora of Mincle ligands have been identified in recent years, and several of these show much promise as vaccine adjuvants for diseases, including M.Tb, HIV-1, Malaria, and Chlamydia, as well as for therapeutic anti-cancer vaccines.